{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:36:25Z","timestamp":1792816585763,"version":"4.5.0"},"reference-count":79,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T00:00:00Z","timestamp":1650585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>The diversity of autologous cells being used and investigated for cancer therapy continues to increase. Mast cells (MCs) are tissue cells that contain a unique set of anti-cancer mediators and are found in and around tumors. We sought to exploit the anti-tumor mediators in MC granules to selectively target them to tumor cells using tumor specific immunoglobin E (IgE) and controllably trigger release of anti-tumor mediators upon tumor cell engagement. We used a human HER2\/<jats:italic>neu<\/jats:italic>-specific IgE to arm human MCs through the high affinity IgE receptor (Fc\u03b5RI). The ability of MCs to bind to and induce apoptosis of HER2\/<jats:italic>neu<\/jats:italic>-positive cancer cells <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic> was assessed. The interactions between MCs and cancer cells were investigated in real time using confocal microscopy. The mechanism of action using cytotoxic MCs was examined using gene array profiling. Genetically manipulating autologous MC to assess the effects of MC-specific mediators have on apoptosis of tumor cells was developed using siRNA. We found that HER2\/<jats:italic>neu<\/jats:italic> tumor-specific IgE-sensitized MCs bound, penetrated, and killed HER2\/<jats:italic>neu<\/jats:italic>-positive tumor masses <jats:italic>in vitro<\/jats:italic>. Tunneling nanotubes formed between MCs and tumor cells are described that parallel tumor cell apoptosis. In solid tumor, human breast cancer (BC) xenograft mouse models, infusion of HER2\/<jats:italic>neu<\/jats:italic> IgE-sensitized human MCs co-localized to BC cells, decreased tumor burden, and prolonged overall survival without indications of toxicity. Gene microarray of tumor cells suggests a dependence on TNF and TGF\u03b2 signaling pathways leading to apoptosis. Knocking down MC-released tryptase did not affect apoptosis of cancer cells. These studies suggest MCs can be polarized from Type I hypersensitivity-mediating cells to cytotoxic cells that selectively target tumor cells and specifically triggered to release anti-tumor mediators. A strategy to investigate which MC mediators are responsible for the observed tumor killing is described so that rational decisions can be made in the future when selecting which mediators to target for deletion or those that could further polarize them to cytotoxic MC by adding other known anti-tumor agents. Using autologous human MC may provide further options for cancer therapeutics that offers a unique anti-cancer mechanism of action using tumor targeted IgE\u2019s.<\/jats:p>","DOI":"10.3389\/fonc.2022.871390","type":"journal-article","created":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T05:29:18Z","timestamp":1650605358000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["Human Tumor Targeted Cytotoxic Mast Cells for Cancer Immunotherapy"],"prefix":"10.3389","volume":"12","author":[{"given":"Mohammad","family":"Fereydouni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elnaz","family":"Ahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parth","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Motaghed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Dellinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean D.","family":"Metcalfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhi","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Hyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tal","family":"Kafri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aadra P.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Dellinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"Kepley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00424","article-title":"Are Mast Cells MASTers in Cancer","volume":"8","author":"Varricchi","year":"2017","journal-title":"Front Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.imlet.2019.03.011","article-title":"Mast Cells: A Double-Edged Sword in Cancer","volume":"209","author":"Derakhshani","year":"2019","journal-title":"Immunol Lett"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1164\/rccm.2609002","article-title":"The Mouse Trap: It Still Yields Few Answers in Asthma","volume":"174","author":"Wenzel","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.immuni.2012.07.007","article-title":"Widespread Immunological Functions of Mast Cells: Fact or Fiction","volume":"37","author":"Rodewald","year":"2012","journal-title":"Immunity"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.5.2731","article-title":"Of Mice and Not Men: Differences Between Mouse and Human Immunology","volume":"172","author":"Mestas","year":"2004","journal-title":"J Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-01-380121","article-title":"Properties of Mouse and Human IgG Receptors and Their Contribution to Disease Models","volume":"119","author":"Bruhns","year":"2012","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/bph.14535","article-title":"Histamine Receptors and Cancer Pharmacology: An Update","volume":"177","author":"Massari","year":"2020","journal-title":"Br J Pharmacol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-019-0636-x","article-title":"Study of the Antitumour Effects and the Modulation of Immune Response by Histamine in Breast Cancer","volume":"122","author":"Nicoud","year":"2020","journal-title":"Br J Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/346274a0","article-title":"Mast Cells as a Source of Both Preformed and Immunologically Inducible TNF-\u2021\/Cachectin","volume":"346","author":"Gordon","year":"1990","journal-title":"Nature"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00138","article-title":"Human Mast Cells From Adipose Tissue Target and Induce Apoptosis of Breast Cancer Cells","volume":"10","author":"Plotkin","year":"2019","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s12967-018-1611-7","article-title":"Unleashing Endogenous TNF-Alpha as a Cancer Immunotherapeutic","volume":"16","author":"Josephs","year":"2018","journal-title":"J Trans Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2016-0141","article-title":"Recent Progress in GM-CSF-Based Cancer Immunotherapy","volume":"9","author":"Yan","year":"2017","journal-title":"Immunotherapy"},{"key":"B13","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/antib9030034","article-title":"Monoclonal Antibodies in Cancer Therapy","volume":"9","author":"Zahavi","year":"2020","journal-title":"Antibodies"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-13725-4_6","article-title":"IgE Immunotherapy Against Cancer","volume":"388","author":"Leoh","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3390\/antib9040055","article-title":"IgE Antibodies Against Cancer: Efficacy and Safety","volume":"9","author":"Chauhan","year":"2020","journal-title":"Antibodies"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/35037021","article-title":"Signalling Through the High-Affinity IgE Receptor Fc epsilonRI","volume":"402","author":"Turner","year":"1999","journal-title":"Nature"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00424","article-title":"Are Mast Cells MASTers in Cancer","volume":"8","author":"Varricchi","year":"2017","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-012-1299-0","article-title":"Using the Allergic Immune System to Target Cancer: Activity of IgE Antibodies Specific for Human CD20 and MUC1","volume":"61","author":"Teo","year":"2012","journal-title":"Cancer Immunol Immunother"},{"key":"B19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1056\/NEJMra043186","article-title":"Trastuzumab\u2013Mechanism of Action and Use in Clinical Practice","volume":"357","author":"Hudis","year":"2007","journal-title":"N Engl J Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2017.06.003","article-title":"An Optimized Protocol for the Generation and Functional Analysis of Human Mast Cells From CD34(+) Enriched Cell Populations","volume":"448","author":"Yin","year":"2017","journal-title":"J Immunol Methods"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1752-8062.2010.00212.x","article-title":"A New Class of Human Mast Cell and Peripheral Blood Basophil Stabilizers That Differentially Control Allergic Mediator Release","volume":"3","author":"Norton","year":"2010","journal-title":"Clin Transl Sci"},{"key":"B22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1532-429X-15-7","article-title":"Functionalization of Gadolinium Metallofullerenes for Detecting Atherosclerotic Plaque Lesions by Cardiovascular Magnetic Resonance","volume":"15","author":"Dellinger","year":"2013","journal-title":"J Cardiovasc Magnetic Resonance: Off J Soc Cardiovasc Magnetic Resonance"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1177\/37.10.2674273","article-title":"Detection of MCT and MCTC Types of Human Mast Cells by Immunohistochemistry Using New Monoclonal Anti-Tryptase and Anti-Chymase Antibodies","volume":"37","author":"Irani","year":"1989","journal-title":"J Histochem Cytochem"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1186\/2051-1426-2-7","article-title":"Targeting Tumor-Necrosis Factor Receptor Pathways for Tumor Immunotherapy","volume":"2","author":"Schaer","year":"2014","journal-title":"J Immunother Cancer"},{"key":"B25","article-title":"Overexpression of CST4 Promotes Gastric Cancer Aggressiveness by Activating the ELFN2 Signaling Pathway","volume":"7","author":"Zhang","year":"2017","journal-title":"Am J Cancer Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.2305","article-title":"Overexpression of Secretagogin Inhibits Cell Apoptosis and Induces Chemoresistance in Small Cell Lung Cancer Under the Regulation of miR-494","volume":"5","author":"Bai","year":"2014","journal-title":"Oncotarget"},{"key":"B27","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12885-019-5369-y","article-title":"Expression and Activity of the Calcitonin Receptor Family in a Sample of Primary Human High-Grade Gliomas","volume":"19","author":"Ostrovskaya","year":"2019","journal-title":"BMC Cancer"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.9343","article-title":"HEY2, a Target of miR-137, Indicates Poor Outcomes and Promotes Cell Proliferation and Migration in Hepatocellular Carcinoma","volume":"7","author":"Wu","year":"2016","journal-title":"Oncotarget"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-16-0576","article-title":"Hey Factors at the Crossroad of Tumorigenesis and Clinical Therapeutic Modulation of Hey for Anticancer Treatment","volume":"16","author":"Liu","year":"2017","journal-title":"Mol Cancer Ther"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.omto.2020.06.020","article-title":"LGR6 Promotes Tumor Proliferation and Metastasis Through Wnt\/\u03b2-Catenin Signaling in Triple-Negative Breast Cancer","volume":"18","author":"Kong","year":"2020","journal-title":"Mol Ther Oncolytics"},{"key":"B31","doi-asserted-by":"crossref","DOI":"10.31219\/osf.io\/sj2fb","volume-title":"MATK Is Differentially Expressed in the Tumors of Breast Cancer Patients Treated With Trastuzumab","author":"Mamoor","year":"2020"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jbior.2014.04.002","article-title":"An Expanding Role for RAS GTPase Activating Proteins (RAS GAPs) in Cancer","volume":"55","author":"Maertens","year":"2014","journal-title":"Adv Biol Regul"},{"key":"B33","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3390\/cancers11060797","article-title":"The Metallophosphoesterase-Domain-Containing Protein 2 (MPPED2) Gene Acts as Tumor Suppressor in Breast Cancer","volume":"11","author":"Pellecchia","year":"2019","journal-title":"Cancers"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.5483\/BMBRep.2019.52.3.019","article-title":"Interleukin-32: Frenemy in Cancer","volume":"52","author":"Han","year":"2019","journal-title":"BMB Rep"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1166\/jnn.2019.16404","article-title":"Ginsenoside Rh2 Inhibits Angiogenesis in Prostate Cancer by Targeting Cnnm1","volume":"19","author":"Huang","year":"2019","journal-title":"J Nanosci Nanotechnol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.12664","article-title":"Filamin A Interacting Protein 1-Like Expression Inhibits Progression in Colorectal Cancer","volume":"7","author":"Park","year":"2016","journal-title":"Oncotarget"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1934602100","article-title":"The BCSC-1 Locus at Chromosome 11q23-Q24 is a Candidate Tumor Suppressor Gene","volume":"100","author":"Martin","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"B38","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/path.4995","article-title":"Synaptopodin-2 Suppresses Metastasis of Triple-Negative Breast Cancer via Inhibition of YAP\/TAZ Activity","volume":"244","author":"Liu","year":"2018","journal-title":"J Pathol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.3390\/cancers11101553","article-title":"ALDH1A2 Is a Candidate Tumor Suppressor Gene in Ovarian Cancer","volume":"11","author":"Choi","year":"2019","journal-title":"Cancers"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0229834","article-title":"MPV17 Does Not Control Cancer Cell Proliferation","volume":"15","author":"Canonne","year":"2020","journal-title":"PloS One"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1101\/2021.03.23.436667","article-title":"PRSS2 Promotes Tumor Growth and Progression by Repressing Tsp-1 in the Tumor Microenvironment via Binding to LRP1","author":"Sui","year":"2021","journal-title":"bioRxiv"},{"key":"B42","doi-asserted-by":"publisher","first-page":"019","DOI":"10.1186\/s10020-019-0111-4","article-title":"PRSS1 Mutation: A Possible Pathomechanism of Pancreatic Carcinogenesis and Pancreatic Cancer","volume":"25","author":"Liu","year":"2019","journal-title":"Mol Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.559230","article-title":"The Clinical Significance and Mechanisms of REG4 in Human Cancers","volume":"10","author":"Zhang","year":"2021","journal-title":"Front Oncol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.27030","article-title":"PRKAR2B Promotes Prostate Cancer Metastasis by Activating Wnt\/\u03b2-Catenin and Inducing Epithelial-Mesenchymal Transition","volume":"119","author":"Sha","year":"2018","journal-title":"J Cell Biochem"},{"key":"B45","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41419-021-03646-3","article-title":"NDUFA4L2 Promotes Glioblastoma Progression, Is Associated With Poor Survival, and can be Effectively Targeted by Apatinib","volume":"12","author":"Chen","year":"2021","journal-title":"Cell Death Dis"},{"key":"B46","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13059-020-02035-x","article-title":"Whole-Genome Sequencing of Glioblastoma Reveals Enrichment of Non-Coding Constraint Mutations in Known and Novel Genes","volume":"21","author":"Sakthikumar","year":"2020","journal-title":"Genome Biol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1158\/1541-7786.MCR-11-0519","article-title":"Emerging Roles of Angiopoietin-Like 4 in Human Cancer","volume":"10","author":"Tan","year":"2012","journal-title":"Mol Cancer Res"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.2500\/108854194778702946","article-title":"Tryptase: A Clinical Indicator of Mast Cell-Dependent Events","volume":"15","author":"Schwartz","year":"1994","journal-title":"Allergy Proc"},{"key":"B49","doi-asserted-by":"publisher","first-page":"154702","DOI":"10.1155\/2014\/154702","article-title":"Targeting Mast Cells Tryptase in Tumor Microenvironment: A Potential Antiangiogenetic Strategy","volume":"2014","author":"Ammendola","year":"2014","journal-title":"BioMed Res Int"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3892\/ijo_00000319","article-title":"Tryptase-Positive Mast Cells Correlate With Angiogenesis in Early Breast Cancer Patients","volume":"35","author":"Ranieri","year":"2009","journal-title":"Int J Oncol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119458","article-title":"Human Mast Cells Stimulate Vascular Tube Formation. Tryptase Is a Novel, Potent Angiogenic Factor","volume":"99","author":"Blair","year":"1997","journal-title":"J Clin Invest"},{"key":"B52","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/s41419-019-1879-4","article-title":"Exosome-Mediated Uptake of Mast Cell Tryptase Into the Nucleus of Melanoma Cells: A Novel Axis for Regulating Tumor Cell Proliferation and Gene Expression","volume":"10","author":"Rabelo Melo","year":"2019","journal-title":"Cell Death Dis"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3892\/or.2019.7335","article-title":"CAR T Cell Therapy: A New Era for Cancer Treatment (Review)","volume":"42","author":"Mohanty","year":"2019","journal-title":"Oncol Rep"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar6711","article-title":"CAR T Cell Immunotherapy for Human Cancer","volume":"359","author":"June","year":"2018","journal-title":"Science"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02804","article-title":"Current State of Dendritic Cell-Based Immunotherapy: Opportunities for In Vitro Antigen Loading of Different DC Subsets","volume":"9","author":"Huber","year":"2018","journal-title":"Front Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-019-0052-1","article-title":"NK Cells for Cancer Immunotherapy","volume":"19","author":"Shimasaki","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"B57","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1158\/2326-6066.CIR-18-0494","article-title":"Activated Eosinophils Exert Antitumorigenic Activities in Colorectal Cancer","volume":"7","author":"Reichman","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.02100","article-title":"Plasticity in Pro- and Anti-Tumor Activity of Neutrophils: Shifting the Balance","volume":"11","author":"Furumaya","year":"2020","journal-title":"Front Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6074.TUMIMM18-PR07","article-title":"Human Chimeric Antigen Receptor Macrophages for Cancer Immunotherapy","volume":"8","author":"Klichinsky","year":"2020","journal-title":"Nat Biotechnol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2007.05.001","article-title":"Human-Hemato-Lymphoid-System Mice: Opportunities and Challenges","volume":"26","author":"Manz","year":"2007","journal-title":"Immunity"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2001.116124","article-title":"IgE-Mediated Mast Cell Degranulation and Recovery Monitored by Time-Lapse Photography","volume":"108","author":"Xiang","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-11-4205","article-title":"IgE- and IgE+Ag-Mediated Mast Cell Migration in an Autocrine\/Paracrine Fashion","volume":"105","author":"Kitaura","year":"2005","journal-title":"Blood"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.97.10.971","article-title":"Stem Cell Factor in Mast Cells and Increased Mast Cell Density in Idiopathic and Ischemic Cardiomyopathy","volume":"97","author":"Patella","year":"1998","journal-title":"Circulation"},{"key":"B64","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nm.2278","article-title":"Histamine Deficiency Promotes Inflammation-Associated Carcinogenesis Through Reduced Myeloid Maturation and Accumulation of CD11b+Ly6G+ Immature Myeloid Cells","volume":"17","author":"Yang","year":"2011","journal-title":"Nat Med"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/s41596-019-0288-6","article-title":"Rapid Identification of Human Mast Cell Degranulation Regulators Using Functional Genomics Coupled to High-Resolution Confocal Microscopy","volume":"15","author":"Folkerts","year":"2020","journal-title":"Nat Protoc"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/s41434-018-0039-2","article-title":"Superior Lentiviral Vectors Designed for BSL-0 Environment Abolish Vector Mobilization","volume":"25","author":"Hu","year":"2018","journal-title":"Gene Ther"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.680891","article-title":"Role of Tunneling Nanotubes in Viral Infection, Neurodegenerative Disease, and Cancer","volume":"12","author":"Tiwari","year":"2021","journal-title":"Front Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2016.02.030","article-title":"Nanotube Formation: A Rapid Form of \u201cAlarm Signaling\u201d","volume":"38","author":"Weng","year":"2016","journal-title":"Clin Ther"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0362-8","article-title":"Apoptotic Cell-Derived Exosomes: Messages From Dying Cells","volume":"52","author":"Kakarla","year":"2020","journal-title":"Exp Mol Med"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/nri3607","article-title":"Apoptotic Cell Clearance: Basic Biology and Therapeutic Potential","volume":"14","author":"Poon","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1111\/j.1745-7254.2008.00889.x","article-title":"Tumor Necrosis Factor and Cancer, Buddies or Foes","volume":"29","author":"Wang","year":"2008","journal-title":"Acta Pharmacol Sin"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-021-00584-4","article-title":"TNF in the Era of Immune Checkpoint Inhibitors: Friend or Foe","volume":"17","author":"Chen","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/ncponc0426","article-title":"Technology Insight: Utility of TNF-Alpha-Based Isolated Limb Perfusion to Avoid Amputation of Irresectable Tumors of the Extremities","volume":"3","author":"Grunhagen","year":"2006","journal-title":"Nat Clin Pract Oncol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"764","DOI":"10.3390\/cells9030764","article-title":"On the TRAIL of Better Therapies: Understanding TNFRSF Structure-Function","volume":"9","author":"Vanamee","year":"2020","journal-title":"Cells"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.3390\/cancers11091306","article-title":"Clinical Significance of SERPINA1 Gene and Its Encoded Alpha1-Antitrypsin Protein in NSCLC","volume":"11","author":"Ercetin","year":"2019","journal-title":"Cancers"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2014.02.020","article-title":"Mast Cells as Targets for Immunotherapy of Solid Tumors","volume":"63","author":"Oldford","year":"2015","journal-title":"Mol Immunol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"960","DOI":"10.3390\/cells10040960","article-title":"Tissue-Resident and Recruited Macrophages in Primary Tumor and Metastatic Microenvironments: Potential Targets in Cancer Therapy","volume":"10","author":"Cotechini","year":"2021","journal-title":"Cells"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-20-2990","article-title":"Macrophage-Based Approaches for Cancer Immunotherapy","volume":"81","author":"Anderson","year":"2021","journal-title":"Cancer Res"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1711886","article-title":"Tragedy, Perseverance, and Chance - The Story of CAR-T Therapy","volume":"377","author":"Rosenbaum","year":"2017","journal-title":"N Engl J Med"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.871390\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T16:23:27Z","timestamp":1651163007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.871390\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,22]]},"references-count":79,"alternative-id":["10.3389\/fonc.2022.871390"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.871390","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,22]]},"article-number":"871390"}}